These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 17450683)

  • 1. [Leukotrienes: potential therapeutic targets in cardiovascular diseases].
    Bäck M
    Bull Acad Natl Med; 2006 Oct; 190(7):1511-8; discussion 1518-21. PubMed ID: 17450683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
    Jonsson EW
    Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of receptors and modulatory mechanisms in functional responses to cysteinyl-leukotrienes in smooth muscle.
    Bäck M
    Acta Physiol Scand Suppl; 2002 Feb; 648():1-55. PubMed ID: 11913222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene receptors in atherosclerosis.
    Bäck M; Hansson GK
    Ann Med; 2006; 38(7):493-502. PubMed ID: 17101540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteinyl leukotrienes and leukotriene B mediate vasoconstriction to arginine vasopressin in rat basilar artery.
    Trandafir CC; Nishihashi T; Ji X; Wang A; Kurahashi K
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1027-33. PubMed ID: 16445567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Leukotrienes as inflammation mediators].
    Woszczek G; Pawliczak R; Kowalski ML
    Postepy Hig Med Dosw; 2003; 57(5):593-610. PubMed ID: 14737972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends.
    Capra V; Thompson MD; Sala A; Cole DE; Folco G; Rovati GE
    Med Res Rev; 2007 Jul; 27(4):469-527. PubMed ID: 16894531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukotriene modifiers in the treatment of cardiovascular diseases.
    Riccioni G; Capra V; D'Orazio N; Bucciarelli T; Bazzano LA
    J Leukoc Biol; 2008 Dec; 84(6):1374-8. PubMed ID: 18794213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of synthetic peptido-leukotrienes on bone resorption in vitro.
    Garcia C; Qiao M; Chen D; Kirchen M; Gallwitz W; Mundy GR; Bonewald LF
    J Bone Miner Res; 1996 Apr; 11(4):521-9. PubMed ID: 8992883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional studies of leukotriene receptors in vascular tissues.
    Walch L; Norel X; Gascard JP; Brink C
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S107-11. PubMed ID: 10673237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of cysteinyl leukotriene CysLT(2) receptor on human coronary artery smooth muscle cells.
    Kamohara M; Takasaki J; Matsumoto M; Matsumoto Si ; Saito T; Soga T; Matsushime H; Furuichi K
    Biochem Biophys Res Commun; 2001 Oct; 287(5):1088-92. PubMed ID: 11587533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy of diseases mediated by 5-lipoxygenase pathway eicosanoids.
    Rubin P; Mollison KW
    Prostaglandins Other Lipid Mediat; 2007 May; 83(3):188-97. PubMed ID: 17481554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor agonists differentially regulate cysteinyl-leukotriene receptor 1 expression and function in human dendritic cells.
    Thivierge M; Stankova J; Rola-Pleszczynski M
    J Allergy Clin Immunol; 2006 May; 117(5):1155-62. PubMed ID: 16675346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteinyl leukotrienes induce P-selectin expression in human endothelial cells via a non-CysLT1 receptor-mediated mechanism.
    Pedersen KE; Bochner BS; Undem BJ
    J Pharmacol Exp Ther; 1997 May; 281(2):655-62. PubMed ID: 9152370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ACh-induced contraction in rat aortas is mediated by the Cys Lt1 receptor via intracellular calcium mobilization in smooth muscle cells.
    Mazzetti L; Franchi-Micheli S; Nistri S; Quattrone S; Simone R; Ciuffi M; Zilletti L; Failli P
    Br J Pharmacol; 2003 Feb; 138(4):707-15. PubMed ID: 12598425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics.
    Singh RK; Gupta S; Dastidar S; Ray A
    Pharmacology; 2010; 85(6):336-49. PubMed ID: 20516735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteinyl leukotriene receptors.
    Evans JF
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():587-97. PubMed ID: 12432945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets?
    Sharma JN; Mohammed LA
    Inflammopharmacology; 2006 Mar; 14(1-2):10-6. PubMed ID: 16835707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelium-dependent vascular responses induced by leukotriene B4.
    Bäck M; Sakata K; Qiu H; Haeggström JZ; Dahlén SE
    Prostaglandins Other Lipid Mediat; 2007 May; 83(3):209-12. PubMed ID: 17481557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigs.
    Yonetomi Y; Sekioka T; Kadode M; Kitamine T; Kamiya A; Matsumura N; Fujita M; Kawabata K
    Eur J Pharmacol; 2015 May; 754():98-104. PubMed ID: 25704617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.